Cite
MLA Citation
James Gilleen et al.. “The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial.” Journal of psychopharmacology, vol. 35, 2021, pp. 15–22. http://access.bl.uk/ark:/81055/vdc_100112308696.0x000009